Tweet Archive for hashtag “#Botox” « page 15

Consensus Panel’s on the Use of 3 BoNT-A Products in Facial Aesthetics aes.sagepub.com/content/33/1_s… #Xeomin #Bocouture #Botox #Dysport #Azzalure

5:52pm Jun 20 2013 —

A Review of OBoNT-A aes.sagepub.com/content/33/1_s… #Botox #Vistabel #Allergan

5:38pm Jun 20 2013 —

Novel muscle relaxant, Galderma Initiates Clinical Development reuters.com/article/2013/0… #Galderma in #cosmetic #dermatology #Botox competitor

6:27am Jun 10 2013 —

RT @NeilSadickMD: Botox May Lose Effectiveness Over Time bit.ly/13z3VGf #botox #beauty #azzalure #bocouture #CosmeticDermatology

in reply to NeilSadickMD — 11:56am May 17 2013 —

Long-term efficacy and respective potencies of BoNT A & B: randomized, double-blind study onlinelibrary.wiley.com/doi/10.1111/j.… #Allergan #Botox #Neurobloc

11:31am Apr 12 2013 —

Botulax a new BoNTA presented #AMWC; only data on file vs #Botox. No publised data this is very weird and awkward. #cosmetic #dermatology

4:40am Apr 5 2013 —

Johnson & Johnson may soon cause frown lines at Allergan. Indeed interesting reuters.com/article/2013/0… $JnJ #Botox #wrinkles #aging #rhytides

1:47pm Apr 4 2013 —

Preferences OBoNTA #Botox and IBoNTA #Xeomin in the Treatment of Blepharospasm. Benchmark for #cosmetic #dermatology journals.lww.com/op-rs/Abstract…

8:04am Apr 4 2013 —

An evidence-based review of botulinum toxin applications in non-cosmetic head and neck conditions. ncbi.nlm.nih.gov/pubmed/23476731 #Botox #Allergan

7:54am Mar 13 2013 —

Excessive Columellar Show: Causes, Presentations & New Therapeutic Approach with Ona BoNT-A onlinelibrary.wiley.com/doi/10.1111/ds… #Allergan #Botox #Vistabel

2:51am Jan 21 2013 —